Abstract
Hypertension in neonates, although described since the 1970s, remains difficult to define precisely because of the different factors that affect blood pressure in the neonatal period, as well as the limited normative data on neonatal blood pressure values. This makes careful blood pressure measurement of paramount importance. Once hypertension is identified, the cause can usually be identified with careful diagnostic evaluation. The most common causes are umbilical catheter-associated thrombosis, renal parenchymal disease, and chronic lung disease. Since data on use of antihypertensive medications in this age group are extremely limited, treatment is empiric and often relies on clinical experience. Available data suggest that long-term outcomes are usually good, with eventual resolution of hypertension in most infants. This chapter will address these main points in the evaluation of neonates with suspected hypertension.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adelman RD. Neonatal hypertension. Pediatr Clin N Am. 1978;25:99–110.
Watkinson M. Hypertension in the newborn baby. Arch Dis Child Fetal Neonatal Ed. 2002;86:F78–81.
Allegaert K, Smits A, van den Anker JN. Drug evaluation studies in neonates: how to overcome the current limitations. Expert Rev Clin Pharmacol. 2018;11:387–96.
Dionne JM, Abitbol CL, Flynn JT. Hypertension in infancy: diagnosis, management and outcome. Pediatr Nephrol. 2012;27:17–32. Erratum in: Pediatr Nephrol 27:159-60
Dionne JM. Neonatal and infant hypertension. In: Flynn JT, Ingelfinger JR, Redwine KM, editors. Pediatric hypertension. 4rd ed. New York: Springer Science+Business Media; 2018. p. 539–63.
Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140:e20171904.
Zubrow AB, Hulman S, Kushner H, Falkner B. Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. J Perinatol. 1995;15:470–9.
Pejovic B, Peco-Antic A, Marinkovic-Eric J. Blood pressure in non-critically ill preterm and full-term neonates. Pediatr Nephrol. 2007;22:249–57.
Georgieff MK, Mills MM, Gómez-Marín O, Sinaiko AR. Rate of change of blood pressure in premature and full term infants from birth to 4 months. Pediatr Nephrol. 1996;10:152–5.
Lalan S, Blowey D. Comparison between oscillometric and intra-arterial blood pressure measurements in ill preterm and full-term neonates. J Am Soc Hypertens. 2014;8:36–44. Erratum in: J Am Soc Hypertens. 2018; 12:479
Kent AL, Chaudhari T. Determinants of neonatal blood pressure. Curr Hypertens Rep. 2013;15:426–32.
Sadoh WE, Ibhanesehbor SE, Monguno AM, Gubler DJ. Predictors of newborn systolic blood pressure. West Afr J Med. 2010;29:86–90.
Mildenhall L, Battin M, Bevan C, et al. Repeat prenatal corticosteroid doses do not alter neonatal blood pressure or myocardial thickness: randomized, controlled trial. Pediatrics. 2009;123:e646–52.
Dagle JM, Fisher TJ, Haynes SE, Berends SK, Brophy PD, Horriss FH, Murray JC. Cytochrome P450 (CYP2D6) genotype is associated with elevated systolic blood pressure in preterm infants after discharge from the neonatal intensive care unit. J Pediatr. 2011;159:104–9.
Lurbe E, Garcia-Vicent C, Torro I, Fayos JL, Aguillar F, de Llano JM, Fuentes G, Redon J. First-year blood pressure increase steepest in low birthweight newborns. J Hypertens. 2007;25:81–6.
Kraut EJ, Boohaker LJ, Askenazi DJ, et al. Incidence of neonatal hypertension from a large multicenter study [assessment of worldwide acute kidney injury epidemiology in neonates-AWAKEN]. Pediatr Res. 2018.
Seliem WA, Falk MC, Shadbolt B, Kent AL. Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up. Pediatr Nephrol. 2007;22:2081–7.
Blowey DL, Duda PJ, Stokes P, Hall M. Incidence and treatment of hypertension in the neonatal intensive care unit. J Am Soc Hypertens. 2011;5(6):478–83.
Friedman AL, Hustead VA. Hypertension in babies following discharge from a neonatal intensive care unit. Pediatr Nephrol. 1987;1:30–4.
Shah AB, Hashmi SS, Sahulee R, et al. Characteristics of systemic hypertension in preterm children. J Am Soc Hypertens. 2015;17:364–70.
Jenkins RD, Aziz JK, Gievers LL, et al. Characteristics of hypertension in premature infants with and without chronic lung disease: a long-term multi-center study. Pediatr Nephrol. 2017;32:2115–24.
Neal WA, Reynolds JW, Jarvis CW, Williams HJ. Umbilical artery catheterization: demonstration of arterial thrombosis by aortography. Pediatrics. 1972;50:6–13.
Bauer SB, Feldman SM, Gellis SS, et al. Neonatal hypertension: a complication of umbilical-artery catheterization. N Engl J Med. 1975;293:1032–3.
Seibert JJ, Taylor BJ, Williamson SL, et al. Sonographic detection of neonatal umbilical-artery thrombosis: clinical correlation. Am J Roetgenol. 1987;148:965–8.
Andrew ME, Monagle P, deVeber G, Chan AK. Thromboembolic disease and antithrombotic therapy in newborns. Hematology Am Soc Hematol Educ Program. 2001;2001:358–74.
Boo NY, Wong NC, Zulkifli SS, Lye MS. Risk factors associated with umbilical vascular catheter-associated thrombosis in newborn infants. J Paediatr Child Health. 1999;35:460–5.
Barrington KJ. Umbilical artery catheters in the newborn: effects of position of the catheter tip. Cochrane Database Syst Rev. 1999;(2):CD000505.
Lau KK, Stoffman JM, Williams S. Neonatal renal vein thrombosis: review of the English-language literature between 1992 and 2006. Pediatrics. 2007;120:e1278–84.
Marks SD, Massicotte MP, Steele BT, et al. Neonatal renal venous thrombosis: clinical outcomes and prevalence of prothrombotic disorders. J Pediatr. 2005;146:811–6.
Resontoc LP, Yap HK. Renal vascular thrombosis in the newborn. Pediatr Nephrol. 2016;31:907–15.
Tullus K, Brennan E, Hamilton G, et al. Renovascular hypertension in children. Lancet. 2008;371:1453–63.
Attia TH, Abd Alhamed MM, Selim MF, et al. Idiopathic arterial calcification of infancy: case report. J Radiol Case Rep. 2015;9:32–40.
Guay-Woodford LM, Desmond RA. Autosomal recessive polycystic kidney disease: the clinical experience in North America. Pediatrics. 2003;111:1072–80.
Gilboa N, Urizar RE. Severe hypertension in newborn after pyeloplasty of hydronephrotic kidney. Urology. 1983;22:179–82.
Selewski DT, Charlton JR, Jetton JG, et al. Neonatal acute kidney injury. Pediatrics. 2015;136:e463–73.
Moralıoğlu S, Celayir AC, Bosnalı O, Pektas OZ, Bulut IK. Single center experience in patients with unilateral multicystic dysplastic kidney. J Pediatr Urol. 2014;10:763–8.
Abman SH, Warady BA, Lum GM, Koops BL. Systemic hypertension in infants with bronchopulmonary dysplasia. J Pediatr. 1984;104:928–31.
Abman SH. Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed. 2002;87:F15–8.
Sehgal A, Malikiwi A, Paul E, et al. Systemic arterial stiffness in infants with bronchopulmonary dysplasia: potential cause of systemic hypertension. J Perinatol. 2016;36:564–9.
Scholz T, Reinking BE. Congenital heart disease. In: Gleason CA, Juul S, editors. Avery’s diseases of the Newborn. 10th ed. Philadelphia, PA: Elsevier; 2018. p. 801–27.
Lee MG, Kowalski R, Galati JC, et al. Twenty-four-hour ambulatory blood pressure monitoring detects a high prevalence of hypertension late after coarctation repair in patients with hypoplastic arches. J Thorac Cardiovasc Surg. 2012;144:1110–6.
Durand M, Sangha B, Cabal LA, et al. Cardiopulmonary and intracranial pressure changes related to endotracheal suctioning in preterm infants. Crit Care Med. 1989;17:506–10.
Maas MH, Cransberg K, van Grotel M, et al. Renin-induced hypertension in Wilms tumor patients. Pediatr Blood Cancer. 2007;48:500–3.
Abiramalatha T, Sherba B, Joseph R, Thomas N. Unusual complications of placental chorioangioma: consumption coagulopathy and hypertension in a preterm newborn. BMJ Case Rep. 2016;2016:pii: bcr2016215734.
Peranteau WH, Tharakan SJ, Partridge E, et al. Systemic hypertension in giant omphalocele: an underappreciated association. J Pediatr Surg. 2015;50:1477–80.
Marinelli KA, Burke GS, Herson VC. Effects of dexamethasone on blood pressure in premature infants with bronchopulmonary dysplasia. J Pediatr. 1997;130:594–602.
Merritt JC, Kraybill EN. Effect of mydriatics on blood pressure in premature infants. J Pediatr Ophthalmol Strabismus. 1981;18:42–6.
Vehaskari VM. Heritable forms of hypertension. Pediatr Nephrol. 2009;24:1929–37.
Simonetti GD, Mohaupt MG, Bianchetti MG. Monogenic forms of hypertension. Eur J Pediatr. 2012;171:1433–9.
Toka HR, Koshy JM, Hariri A. The molecular basis of blood pressure variation. Pediatr Nephrol. 2013;28:387–99.
Nitschke Y, Rutsch F. Genetics in arterial calcification: lessons learned from rare diseases. Trends Cardiovasc Med. 2012;22:145–9.
Becker JA, Short BL, Martin GR. Cardiovascular complications adversely affect survival during extracorporeal membrane oxygenation. Crit Care Med. 1998;26:1582–6.
Boedy RF, Goldberg AK, Howell CG, et al. Incidence of hypertension in infants on extracorporeal membrane oxygenation. J Pediatr Surg. 1990;25:258–61.
Butt WW, Whyte H. Blood pressure monitoring in neonates: comparison of umbilical and peripheral artery catheter measurements. J Pediatr. 1984;105:630–2.
O’Shea J, Dempsey EM. A comparison of blood pressure measurements in newborns. Am J Perinatol. 2009;26:113–6.
Yiallourou SR, Poole H, Prathivadi P, et al. The effects of dummy/pacifier use on infant blood pressure and autonomic activity during sleep. Sleep Med. 2014;15:1508–16.
Satoh M, Inoue R, Tada H, et al. Reference values and associated factors for Japanese newborns’ blood pressure and pulse rate. J Hypertens. 2016;34:1578–85.
Stebor AD. Basic principles of noninvasive blood pressure measurement in infants. Adv Neonatal Care. 2005;5:252–61.
Nwankwo MU, Lorenz JM, Gardiner JC. A standard protocol for blood pressure measurement in the newborn. Pediatrics. 1997;99:e10.
Crossland DS, Furness JC, Abu-Harb M, Sadagopan SN, Wren C. Variability of four limb blood pressure in normal neonates. Arch Dis Child Fetal Neonatal Ed. 2004;89:F325–7.
Richer C, Hornych H, Amiel-Tison C, Relier JP, Giudicelli JF. Plasma renin activity and its postnatal development in preterm infants. Preliminary report. Biol Neonate. 1977;31:301–4.
Roth CG, Spottswood SE, Chan JC, Roth KS. Evaluation of the hypertensive infant: a rational approach to diagnosis. Radiol Clin N Am. 2003;41:931–44.
Karakurt N, Beşbaş N, Bozacı AC, et al. Antenatal hydronephrosis: a single center’s experience and follow-up strategies. Turk J Pediatr. 2015;57:560–5.
Vo NJ, Hammelman BD, Racadio JM, et al. Anatomic distribution of renal artery stenosis in children: implications for imaging. Pediatr Radiol. 2006;36:1032–6.
Peco-Antic A, Djukic M, Sagic D, et al. Severe renovascular hypertension in an infant with congenital solitary pelvic kidney. Pediatr Nephrol. 2006;21:437–40.
Louw J, Brown S, Thewissen L, Gewillig M, et al. Neonatal circulatory failure due to acute hypertensive crisis: clinical and echocardiographic clues. Cardiovasc J Afr. 2013;24:72–5.
Xiao N, Tandon A, Goldstein S, Lorts A. Cardiogenic shock as the initial presentation of neonatal systemic hypertension. J Neonatal Perinatal Med. 2013;6:267–72.
Sahu R, Pannu H, Yu R, Stete S, Bricker JT, Gupta-Malhotra M. Systemic hypertension requiring treatment in the neonatal intensive care unit. J Pediatr. 2013;163:84–8.
Ravisankar S, Kuehn D, Clark RH, et al. Antihypertensive drug exposure in premature infants from 1997 to 2013. Cardiol Young. 2016;27:905–11.
Dionne JM, Flynn JT. Management of severe hypertension in the newborn. Arch Dis Child. 2017;102:1176–9.
Perlman JM. The relationship between systemic hemodynamic perturbations and periventricular-intraventricular hemorrhage—a historical perspective. Semin Pediatr Neurol. 2009;16:191–9.
Gouyon JB, Geneste B, Semama DS, et al. Intravenous nicardipine in hypertensive preterm infants. Arch Dis Child Fetal Neonatal Ed. 1997;76:F126–7.
Flynn JT, Mottes TA, Brophy PD, al K. Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr. 2001;139:38–43.
Benitz WE, Malachowski N, Cohen RS, et al. Use of sodium nitroprusside in neonates: efficacy and safety. J Pediatr. 1985;106:102–10.
Wiest DB, Garner SS, Uber WE, Sade RM. Esmolol for the management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg. 1998;115:890–7.
Thomas CA, Moffett BS, Wagner JL, et al. Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children. Pediatr Crit Care Med. 2011;12:28–32.
Flynn J, Warnick S. Isradipine treatment of hypertension in children: a single-center experience. Pediatr Nephrol. 2002;17:748–53.
Miyashita Y, Peterson D, Rees JM, Flynn JT. Isradipine for treatment of acute hypertension in hospitalized children and adolescents. J Clin Hypertens. 2010;12:850–5.
Kao LC, Durand DJ, McCrea RC, et al. Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia. J Pediatr. 1994;124:772–81.
O’Dea RF, Mirkin BL, Alward CT, Sinaiko AR. Treatment of neonatal hypertension with captopril. J Pediatr. 1988;113:403–6.
Tack ED, Perlman JM. Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr. 1988;112:805–10.
Ku LC, Zimmerman K, Benjamin DK, et al. Safety of Enalapril in infants admitted to the neonatal intensive care unit. Pediatr Cardiol. 2016;38:155–61.
Pandey R, Koshy RG, Dako J. Angiotensin converting enzyme inhibitors induced acute kidney injury in newborn. J Matern Fetal Neonatal Med. 2017;30:748–50.
Tufro-McReddie A, Romano LM, Harris JM, et al. Angiotensin II regulates nephrogenesis and renal vascular development. Am J Phys. 1995;269:F110–5.
Frölich S, Slattery P, Thomas D, et al. Angiotensin II-AT1–receptor signaling is necessary for cyclooxygenase-2–dependent postnatal nephron generation. Kidney Int. 2017;91:818–29.
Snauwaert E, Vande Walle J, De Bruyne P. Therapeutic efficacy and safety of ACE inhibitors in the hypertensive paediatric population: a review. Arch Dis Child. 2016;102:63–71.
Rajpoot DK, Duel B, Thayer K, Shanberg A. Medically resistant neonatal hypertension: revisiting the surgical causes. J Perinatol. 1999;19:582–3.
Bendel-Stenzel M, Najarian JS, Sinaiko AR. Renal artery stenosis in infants: long-term medical treatment before surgery. Pediatr Nephrol. 1996;10:147–51.
Kiessling SG, Wadhwa N, Kriss VM, Iocono J, Desai NS. An unusual case of severe therapy-resistant hypertension in a newborn. Pediatrics. 2007;119:e301–4.
Abdulhannan P, Stahlschmidt J, Subramaniam R. Multicystic dysplastic kidney disease and hypertension: clinical and pathological correlation. J Pediatr Urol. 2011;7:566–8.
Caplan MS, Cohn RA, Langman CB, et al. Favorable outcome of neonatal aortic thrombosis and renovascular hypertension. J Pediatr. 1989;115:291–5.
The Low Birth Weight and Nephron Number Working Group. The impact of kidney development on the life course: a consensus document for action. Nephron. 2017;136:3–49.
Hughson M, Farris AB III, Douglas-Denton R, et al. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int. 2003;63:2113–22.
Keller G, Zimmer G, Mall G, et al. Nephron number in patients with primary hypertension. N Engl J Med. 2003;348:101–8.
Gupta-Malhotra M, Banker A, Shete S, et al. Essential hypertension vs. secondary hypertension among children. Am J Hypertens. 2015;28:73–80.
Shankaran S, Das A, Bauer CR, et al. Fetal origin of childhood disease: intrauterine growth restriction in term infants and risk for hypertension at 6 years of age. Arch Pediatr Adolesc Med. 2006;160:977–81.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Flynn, J.T. (2019). Neonatal Hypertension. In: Lurbe, E., Wühl, E. (eds) Hypertension in Children and Adolescents. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-030-18167-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-18167-3_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-18166-6
Online ISBN: 978-3-030-18167-3
eBook Packages: MedicineMedicine (R0)